Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02783690 · ClinicalTrials.gov registry record · Phase 2
A Trial of 15 Fraction vs 25 Fraction Pencil Beam Scanning Proton Radiotherapy After Mastectomy in Patients Requiring Regional Nodal Irradiation
A Phase 2 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 2
- Development phase
- 88
- Enrollment target
NCT02783690: Completed Phase 2 study, sponsored by Mayo Clinic.
NCT02783690 is a Phase 2 study that has completed, run by Mayo Clinic. The registered enrollment target is 88 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02783690, a Phase 2 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 88 participants
- Enrollment target
Study Summary
This is a randomized controlled trial to determine the safety of 15 fraction vs 25 fraction pencil beam scanning proton radiotherapy after mastectomy in patients requiring regional nodal irradiation. Proton therapy is recognized as a standard option for the delivery of radiotherapy for breast cancer.
Interventions
- RADIATION Hypofractionation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2016-05-18 |
| Est. Completion | 2023-11-18 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02783690
The ClinicalTrials.gov registry entry for NCT02783690 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hypofractionation is the first listed.
NCT02783690 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02783690 about?
NCT02783690 is a clinical study titled "A Trial of 15 Fraction vs 25 Fraction Pencil Beam Scanning Proton Radiotherapy After Mastectomy in Patients Requiring Regional Nodal Irradiation". This is a randomized controlled trial to determine the safety of 15 fraction vs 25 fraction pencil beam scanning proton radiotherapy after mastectomy in patients requiring regional nodal irradiation. Proton therapy is recognized as a standard option for the delivery of radiotherapy for breast cancer...
What is the current status of trial NCT02783690?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 88 participants. The study started on 2016-05-18. Estimated completion is 2023-11-18.
What interventions are being tested in trial NCT02783690?
The interventions under investigation include: Hypofractionation (RADIATION).
Who is sponsoring clinical trial NCT02783690?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.